Lucas Svetlana bought JSPR
July 3, 2025 · Form 4 insider transaction
Lucas Svetlana bought 7,500 shares of Jasper Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,500
Price
$0.00
Total value
N/A
InsiderLucas Svetlana
RoleOfficer, Director
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJuly 3, 2025
Filing dateJuly 3, 2025
Shares owned after7,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders.